Drug hypersensitivity reactions in children in clinical practice: A WAO Statement

ADRs

adverse drug reactions

AERD

aspirin-exacerbated respiratory disease

AGEP

acute generalized exanthematous pustulosis

BAT

basophil activation test

BLs

beta-lactam antibiotics

CFTR

cystic fibrosis transmembrane conductance regulator

DHR

drug hypersensitivity reactions

DIA

drug-induced anaphylaxis

DIES

drug-induced enterocolitis syndrome

DIHS

drug-indued hypersensitivity syndrome

DILI

drug-induced liver injury

DRESS

drug reaction with eosinophilia and systemic symptoms

EAACI

European Academy of Allergy and Clinical Immunology

ELISpot

Ennzyme-linked Immunosorbent Spot

ENDA

European Network on Drug Allergy

FPIES

food protein induced enterocolitis syndrome

GBCM

gadolinium-based contrast media

GVHD

graft-versus-host disease

HLA

human leukocyte antigen

IDHRs

immediate drug hypersensitivity reactions

LTT

lymphocyte transformation test

MHC

major histocompatibility complex

MPE

maculopapular exanthema

MRGPRX2

mas-related G-protein-coupled receptor member X2

NECD

NSAID-exacerbated cutaneous disease

N-ERD

NSAID-exacerbated respiratory disease

NSAIDs

non-steroidal anti-inflammatory drugs

NIDHRs

non-immediate reactions

NIUAAA

NSAID -induced urticaria

angioedema

and anaphylaxis

NBLA

non-betalactam antibiotic

NMBA

neuromuscular blocking agents

NPV

negative predictive value

nsLTP

non-specific lipid transfer protein

POH

peri-operative drug allergy

PI

pharmacological interaction

RDD

rapid drug desensitization

RIME

reactive infectious mucocutaneous eruption

SCARs

severe cutaneous adverse reactions

SJS

Stevens-Johnson Syndrome

SSLR

serum sickness-like reactions

TEN

toxic epidermal necrolysis

TMP-SMX

trimethoprim-sulfamethoxazole

WAO

World Allergy Organization

Comments (0)

No login
gif